Search Results - "HELLER, A. H"

Refine Results
  1. 1

    Pharmacokinetics of a Once-Daily Oral Dose of Moxifloxacin (Bay 12-8039), a New Enantiomerically Pure 8-Methoxy Quinolone by SULLIVAN, J. T, WOODRUFF, M, LETTIERI, J, AGARWAL, V, KROL, G. J, LEESE, P. T, WATSON, S, HELLER, A. H

    Published in Antimicrobial Agents and Chemotherapy (01-11-1999)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses by LETTIERI, J. T, ROGGE, M. C, KAISER, L, ECHOLS, R. M, HELLER, A. H

    Published in Antimicrobial Agents and Chemotherapy (01-05-1992)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    PhRMA Perspective on Population and Individual Bioequivalence by Barrett, Jeffrey S., Batra, Vijay, Chow, Andrew, Cook, Jack, Gould, A. Lawrence, Heller, Allen H., Lo, Man-Wai, Patterson, Scott D., Smith, Brian P., Stritar, Jeffrey A., Vega, Jose M., Zariffa, Névine

    Published in Journal of clinical pharmacology (01-06-2000)
    “…The Food and Drug Administration (FDA) issued a second‐draft guidance in August 1999 on the subject of in vivo bioequivalence, which is based on the concepts…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects by SHAH, A, LETTIERI, J, NIX, D, WILTON, J, HELLER, A. H

    Published in Antimicrobial Agents and Chemotherapy (01-04-1995)
    “…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  5. 5

    Effect of Ciprofloxacin on the Pharmacokinetics and Pharmacodynamics of Warfarin by Israel, Debra S., Stotka, Jennifer, Rock, William, Sintek, Charles D., Kamada, Alan K., Klein, Catherine, Swaim, William R., Pluhar, Robert E., Toscano, John P., Lettieri, John T., Heller, Allen H., Polk, Ron E.

    Published in Clinical infectious diseases (01-02-1996)
    “…To detennine if ciprofloxacin therapy alters the response to warfarin treatment, 36 adult patients attending three university-affiliated outpatient…”
    Get full text
    Journal Article
  6. 6

    Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults by ISAACSOHN, J, ZINNY, M, MAZZU, A, LETTIERI, J, HELLER, A. H

    Published in European journal of clinical pharmacology (01-03-2001)
    “…The pharmacokinetics, safety, and tolerability of cerivastatin, a synthetic HMG-CoA reductase inhibitor were studied in 49 healthy volunteers. In this…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects by Shah, A., Lettieri, J., Blum, R., Millikin, S., Sica, D., Heller, A. H.

    Published in Journal of antimicrobial chemotherapy (01-07-1996)
    “…The pharmacokinetics of intravenous ciprofloxacin and its metabolites were characterized in 42 subjects with various degrees of renal function (group 1, ClCT…”
    Get full text
    Journal Article
  8. 8

    Intra-and Intercontinental Molecular Variability of an Alu Insertion in the 3' Untranslated Region of the LDLR Gene by HELLER, A.H., SALZANO, E.M., BARRANTES, R., KRYLOV, M., BENEVOLENSKAYA, L., ARNETT, F.C., MUNKHBAT, B., MUNKHTUVSHIN, N., TSUJI, K., HUTZ, M.H., CARNESE, F.R., GOICOECHEA, A.S., FREITAS, L.B., BONATTO, S.L.

    Published in Human biology (01-08-2004)
    “…One-hundred three individuals from two Mongolian, two Siberian, and ten native American populations were studied in relation to a 340-bp sequence from an Alu…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers by ISRAEL, D, GILLUM, J. G, TURIK, M, HARVEY, K, FORD, J, DALTON, H, TOWLE, M, ECHOLS, R, HELLER, A. H, POLK, R

    Published in Antimicrobial Agents and Chemotherapy (01-10-1993)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  10. 10

    Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily by Shah, A, Lettieri, J, Kaiser, L, Echols, R, Heller, A H

    Published in Journal of antimicrobial chemotherapy (01-04-1994)
    “…Comparative pharmacokinetics of i.v. and oral ciprofloxacin was studied in 24 healthy male subjects given 400 mg i.v. tds or 750 mg po bd in a randomized,…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Influence of Age on the Safety, Tolerability, and Pharmacokinetics of the Novel HMG-CoA Reductase Inhibitor Cerivastatin in Healthy Male Volunteers by Mazzu, Arthur, Lettieri, John, Kaiser, Lee, Mullican, William, Heller, Allen H.

    Published in Journal of clinical pharmacology (01-08-1998)
    “…The safety, tolerability, and pharmacokinetics of cerivastatin, a novel, synthetic, potent, and highly selective HMG‐CoA reductase inhibitor, were studied in…”
    Get full text
    Journal Article
  14. 14

    Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood by Finberg, R W, Newburger, J W, Mikati, M A, Heller, A H, Burns, J C

    Published in The Journal of pediatrics (01-03-1992)
    “…Because Kawasaki disease is a disorder characterized by lymphocyte activation and immune complex destruction of endothelial cells, we examined the effect of…”
    Get more information
    Journal Article
  15. 15

    Safety and tolerance of intravenous nimodipine by Sramek, J J, Heller, A H, Sundaresan, P R, Lettieri, J, Sawin, S, Cutler, N R

    Published in The Annals of pharmacotherapy (01-10-1994)
    “…To evaluate the safety and tolerance of intravenous nimodipine administered via a peripheral vein in healthy male volunteers. Double-blind, placebo- and…”
    Get more information
    Journal Article
  16. 16

    Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin by Echols, R, Weinstein, M P, O'Keeffe, B, Shah, A, Heller, A H

    Published in Journal of antimicrobial chemotherapy (01-01-1994)
    “…The study compared the pharmacokinetics and pharmacodynamics of ciprofloxacin and ofloxacin in 12 healthy male volunteers with normal renal function. Each…”
    Get more information
    Journal Article
  17. 17

    Preclinical and clinical pharmacology of cerivastatin by Bischoff, Hilmar, Heller, Allen H

    Published in The American journal of cardiology (27-08-1998)
    “…Cerivastatin, a new, entirely synthetic, and enantiomerically pure 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, is pharmacologically…”
    Get full text
    Journal Article
  18. 18

    The influence of age and gender on the pharmacokinetics of moxifloxacin by Sullivan, J T, Lettieri, J T, Liu, P, Heller, A H

    Published in Clinical pharmacokinetics (2001)
    “…Moxifloxacin is a new 8-methoxyfluoroquinolone with a broad antibacterial spectrum. The purpose of the present study was to determine the effects of age and…”
    Get full text
    Journal Article
  19. 19

    Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension by Shah, A, Liu, M C, Vaughan, D, Heller, A H

    Published in Journal of antimicrobial chemotherapy (01-03-1999)
    “…The oral bioequivalence and tolerability of two ciprofloxacin formulations (tablet and suspension) and the effect of food on the absorption of ciprofloxacin…”
    Get full text
    Journal Article
  20. 20

    Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia by Stein, Evan, Isaacsohn, Jonathan, Stoltz, Randall, Mazzu, Arthur, Liu, Ming-Chung, Lane, Cindy, Heller, Allen H.

    Published in The American journal of cardiology (15-05-1999)
    “…Cerivastatin is a third generation hydroxy-methyl-glutaryl-Co-enzyme A (HMG-CoA) reductase inhibitor proven to lower low-density lipoprotein (LDL) cholesterol…”
    Get full text
    Journal Article